Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Light-Chain Amyloidosis”

298 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 298 results

Not applicableStudy completedNCT02257905
What this trial is testing

Allo SCT in Amyloidosis Non-interventional Study

Who this might be right for
AL Amyloidosis
European Society for Blood and Marrow Transplantation 14
Large-scale testing (Phase 3)Study completedNCT04298372
What this trial is testing

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

Who this might be right for
Amyloidosis Cardiac
Seoul National University Hospital 2
Not applicableStudy completedNCT02055534
What this trial is testing

Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 144
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)Study completedNCT00679367
What this trial is testing

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 16
Early research (Phase 1)Study completedNCT05201911
What this trial is testing

Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT06418477
What this trial is testing

Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00002849
What this trial is testing

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 93
Testing effectiveness (Phase 2)Study completedNCT00224393
What this trial is testing

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
The Cleveland Clinic 60
Testing effectiveness (Phase 2)Study completedNCT02015312
What this trial is testing

A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)

Who this might be right for
Light Chain (AL) AmyloidosisCardiac Involvement
Florian Michel 38
Not applicableUnknownNCT06455748
What this trial is testing

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

Who this might be right for
Amyloid Light-chain Amyloidosis
Yongyong MA 20
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT02741999
What this trial is testing

A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early

Who this might be right for
Plasma Cell DyscrasiaMonoclonal Gammopathy
Tufts Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00007995
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Herbert Irving Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05951049
What this trial is testing

AT-02 in Subjects With Systemic Amyloidosis.

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 120
Large-scale testing (Phase 3)Ended earlyNCT01659658
What this trial is testing

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Systemic Light Chain Amyloidosis
Millennium Pharmaceuticals, Inc. 177
Testing effectiveness (Phase 2)Ended earlyNCT03154047
What this trial is testing

Study in Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT00002504
What this trial is testing

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Hoag Memorial Hospital Presbyterian
Not applicableLooking for participantsNCT00898235
What this trial is testing

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

Who this might be right for
Multiple Myeloma
Boston Medical Center 10,000
Next Page